{
  "catalogId": "e0ea61c4-b84f-4d11-9644-62ed5c5d3ca8",
  "name": "SIMVASTATIN TEVA 80 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "128 05 30671 11",
  "treatmentDescriptions": "Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia  Simvastatin-teva is indicated to:     Reduce the risk of total mortality by reducing coronary death ;Reduce the risk of non-fatal myocardial infarction ;Reduce the risk for undergoing myocardial revascularization procedures.      Reduce the risk of stroke and transient ischemic attacks (TIA).   Hyperlipidemia: Simvastatin-teva is indicated as an adjunct to diet to reduce elevated TOTAL-C  LDL-C  Apo B and TG  and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvastatin-teva therefore  lowers the LDL-C/HDL-C and the total-C/HDL-C ratios.   Homozygous familial hypercholesterolemia: Simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol  LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate.   Hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Simvastatin-teva is indicated for the treatment of patients with hypertriglyceridemia ( Fredrickson type IV  hyperlipidemia).  Dysbetalipoproteinemia (Fredrickson type III hyperlipidemia): Simvastatin-teva is also indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia).",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "SIMVASTATIN",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "C10AA01",
      "name": "SIMVASTATIN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "SIMVASTATIN-TEVA 80MG 30TAB",
      "manufacturer": {
        "name": "טבע",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 80.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PE/PVDC/AL",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "4687",
        "yarpa": "59806",
        "pharmasoft": "19715"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 75.3379,
        "retailMargin": 34.5,
        "maxRetailPrice": 101.3294755,
        "maxPriceWithVAT": 119.5687811
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:50.753553",
    "tags": [],
    "smartValidation": {
      "extractedFrom": "SIMVASTATIN-TEVA 80MG 30TAB",
      "processedBy": "smart_validation",
      "matchScore": 0.8166666666666668,
      "status": "corrected",
      "correctedAt": "2025-08-01T16:04:08.741304",
      "previousRegistration": "129 18 30737 00",
      "newRegistration": "128 05 30671 11",
      "apiSource": "SIMVASTATIN TEVA 80 MG"
    }
  },
  "nameHebrew": "סימבסטאטין טבע 80 מ\"ג",
  "registrationDate": "2023-03-31"
}